The Cardiac Membrane Biology Laboratory aims to improve the lives of people suffering cardiac related health issues.
Our research focuses on one of the body’s most crucial molecules – a molecule which is vital for the contraction of heart cells and therefore the pumping of the heart. As we develop a better understanding of this molecule through laboratory-based experiments, we explore treatments for heart failure, irregular heartbeat and heart damage following cancer treatment.
Our laboratory-based research has led to the discovery of a new potential treatment for heart failure. We are about to begin a clinical trial of this approach with our collaborators based in Denmark.
Chair of Cardiology
Medicine, Northern Clinical School
Honorary Senior Research Fellow
Bei Xu – Research Assistant
This project will investigate a new drug combination therapy that has potential benefits in cancer treatment induced heart failure by targeting the sodium/potassium pump function.
This project will investigate a drug combination therapy that has potential benefits in heart failure treatment by targeting the sodium/potassium pump function.
Some recent media:
Posted on: 03 October, 2024
In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials i..... Read more
Category: Research Excellence
Posted on: 07 August, 2024
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the K..... Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 05 July, 2024
A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one ex..... Read more
Category: Research Excellence